Biotechnology
The Biotechnology industry has a total of 593 stocks, with a combined market cap of $1.18 trillion and total revenue of $110.17 billion.
Market Cap
1.18T
Revenue
110.17B
Profits
-39.88B
PE Ratio
n/a
Profit Margin
-36.20%
Dividend Yield
0.04%
593 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 111.05B | 0.56% | 756 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 76.51B | -0.23% | 6,701 | 14.34B |
| 3 | ARGX | argenx SE | 50.17B | -0.32% | 3,095 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 40.90B | - | 635 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.63B | -0.60% | 693 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.43B | 0.38% | 18,794 | - |
| 7 | INSM | Insmed Incorporated | 30.43B | 0.78% | 390 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.33B | -0.46% | 570 | 2.38B |
| 9 | BNTX | BioNTech SE | 28.30B | 0.27% | 12,363 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.81B | 1.42% | 29,710 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 21.04B | 0.38% | 28,093 | 13.31M |
| 12 | SMMT | Summit Therapeutics Inc. | 20.66B | 0.99% | 18,922 | - |
| 13 | INCY | Incyte Corporation | 19.15B | 0.42% | 328 | 5.14B |
| 14 | GMAB | Genmab A/S | 16.71B | 3.66% | 123,598 | 3.72B |
| 15 | BBIO | BridgeBio Pharma, Inc. | 14.89B | 0.83% | 2,474 | 502.08M |
| 16 | ASND | Ascendis Pharma A/S | 14.70B | -0.95% | 2,920 | 845.52M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | 1.57% | 10,235 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.25B | 1.25% | 35 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.11B | 1.39% | 31 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.85B | 1.63% | 12,140 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.59B | 0.77% | 861 | 3.22B |
| 22 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.15B | 1.98% | 3,652 | 1.09B |
| 23 | PRAX | Praxis Precision Medicines, Inc. | 9.49B | 0.05% | 3,137 | 7.46M |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.36B | 1.91% | 348 | 638.50M |
| 25 | TECH | Bio-Techne Corporation | 9.34B | 1.95% | 12,712 | 1.22B |
| 26 | ABVX | ABIVAX Société Anonyme | 9.12B | 2.06% | 22,626 | 5.37M |
| 27 | PCVX | Vaxcyte, Inc. | 8.92B | 2.38% | 279 | - |
| 28 | IBRX | ImmunityBio, Inc. | 8.55B | 2.22% | 210,062 | 113.29M |
| 29 | NUVL | Nuvalent, Inc. | 8.42B | 0.28% | 2,399 | - |
| 30 | CYTK | Cytokinetics, Incorporated | 8.42B | 3.86% | 10,992 | 88.04M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 8.12B | 0.22% | 341 | 1.40B |
| 32 | KRYS | Krystal Biotech, Inc. | 8.03B | - | 3 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.19B | -0.67% | 161 | 39.21M |
| 34 | ERAS | Erasca, Inc. | 7.06B | 1.43% | 63,146 | - |
| 35 | ACLX | Arcellx, Inc. | 6.75B | 0.06% | 787 | 22.29M |
| 36 | APGE | Apogee Therapeutics, Inc. | 6.71B | -0.58% | 162 | - |
| 37 | PTGX | Protagonist Therapeutics, Inc. | 6.61B | -2.15% | 6,039 | 46.02M |
| 38 | BLTE | Belite Bio, Inc | 6.50B | 2.15% | 51 | - |
| 39 | SYRE | Spyre Therapeutics, Inc. | 6.17B | 0.29% | 999 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.11B | 0.05% | 6,710 | 15.00M |
| 41 | CGON | CG Oncology, Inc. | 6.11B | 0.65% | 1,103 | 4.04M |
| 42 | TERN | Terns Pharmaceuticals, Inc. | 6.10B | -0.09% | 2,462 | - |
| 43 | CELC | Celcuity Inc. | 6.09B | 0.78% | 5,205 | - |
| 44 | COGT | Cogent Biosciences, Inc. | 6.09B | 2.94% | 27,348 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 6.00B | 1.92% | 579 | 812.03M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.85B | -1.03% | 183 | 1.73B |
| 47 | IMVT | Immunovant, Inc. | 5.80B | 0.85% | 412 | - |
| 48 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.80B | -0.04% | 92 | 189.76M |
| 49 | MIRM | Mirum Pharmaceuticals, Inc. | 5.71B | 1.09% | 656 | 521.31M |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.54B | 0.21% | 250 | - |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.45B | 1.24% | 13,477 | 7.50M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.45B | 1.83% | 5,857 | 3.51M |
| 53 | TGTX | TG Therapeutics, Inc. | 5.45B | 1.64% | 4,682 | 616.29M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.24B | -0.05% | 12,453 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.91B | 0.16% | 57 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.80B | 0.85% | 184 | 761.41M |
| 57 | LEGN | Legend Biotech Corporation | 4.72B | 1.19% | 10,474 | 1.03B |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | - | 5,215 | 634.21M |
| 59 | LGND | Ligand Pharmaceuticals Incorporated | 4.47B | -1.18% | 652 | 268.09M |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.11B | 1.03% | 1,151 | 7.70M |
| 61 | TNGX | Tango Therapeutics, Inc. | 3.97B | 0.11% | 8,334 | 62.38M |
| 62 | VKTX | Viking Therapeutics, Inc. | 3.95B | 0.90% | 3,307,523 | - |
| 63 | NAMS | NewAmsterdam Pharma Company N.V. | 3.76B | 0.68% | 44,710 | 22.50M |
| 64 | ACAD | ACADIA Pharmaceuticals Inc. | 3.72B | 1.95% | 62 | 1.07B |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.58B | 0.44% | 685 | 490.73M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.52B | 1.08% | 2,517 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.48B | 0.49% | 6,886 | 803.79M |
| 68 | ORKA | Oruka Therapeutics, Inc. | 3.42B | - | 955 | - |
| 69 | GPCR | Structure Therapeutics Inc. | 3.34B | 0.63% | 409 | - |
| 70 | RLAY | Relay Therapeutics, Inc. | 3.20B | 0.66% | 25,626 | 15.36M |
| 71 | DNLI | Denali Therapeutics Inc. | 3.19B | 0.73% | 13,666 | - |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.17B | 1.43% | 4,318 | - |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.17B | 1.33% | 2,380 | 588.99M |
| 74 | KLRA | Kailera Therapeutics, Inc. | 3.17B | 1.51% | 3,186 | - |
| 75 | BEAM | Beam Therapeutics Inc. | 3.09B | 1.48% | 16,899 | 139.74M |
| 76 | RCUS | Arcus Biosciences, Inc. | 3.09B | 0.45% | 3,149 | 247.00M |
| 77 | ALMS | Alumis Inc. | 3.08B | -3.12% | 892 | 24.05M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 2.96B | 2.14% | 192 | 376.07M |
| 79 | VERA | Vera Therapeutics, Inc. | 2.87B | - | 5,639 | - |
| 80 | KOD | Kodiak Sciences Inc. | 2.85B | 2.11% | 3,885 | - |
| 81 | IDYA | IDEAYA Biosciences, Inc. | 2.83B | 1.16% | 1,379 | 218.71M |
| 82 | ELVN | Enliven Therapeutics, Inc. | 2.76B | 0.46% | 5,718 | - |
| 83 | TARS | Tarsus Pharmaceuticals, Inc. | 2.75B | 0.02% | - | 451.36M |
| 84 | MANE | Veradermics, Incorporated | 2.74B | 0.12% | 8 | - |
| 85 | ZLAB | Zai Lab Limited | 2.74B | -0.61% | 203,385 | 460.16M |
| 86 | SLNO | Soleno Therapeutics, Inc. | 2.73B | 0.09% | 3,078 | 190.41M |
| 87 | NKTR | Nektar Therapeutics | 2.73B | -3.22% | 467,037 | 55.23M |
| 88 | CLDX | Celldex Therapeutics, Inc. | 2.71B | 0.73% | 3,148 | 1.55M |
| 89 | IMNM | Immunome, Inc. | 2.70B | 0.61% | 9,174 | 6.94M |
| 90 | IRON | Disc Medicine, Inc. | 2.68B | 1.78% | 6,687 | - |
| 91 | ADMA | ADMA Biologics, Inc. | 2.52B | 0.74% | 20,372 | 510.17M |
| 92 | DFTX | Definium Therapeutics, Inc. | 2.40B | 0.88% | 21,870 | - |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.39B | 0.87% | 1,860 | 673.00M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 2.37B | 0.54% | 642 | - |
| 95 | AAPG | Ascentage Pharma Group International | 2.34B | 1.41% | 8 | 82.08M |
| 96 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | 19,574 | 158.18M |
| 97 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | 2.03% | 3,830 | 2.20B |
| 98 | ADPT | Adaptive Biotechnologies Corporation | 2.19B | 3.00% | 153 | 276.98M |
| 99 | INBX | Inhibrx Biosciences, Inc. | 2.16B | 75.93% | 425,552 | 1.30M |
| 100 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | 0.57% | 1,568 | 283.06M |
| 101 | CAPR | Capricor Therapeutics, Inc. | 2.11B | 3.28% | 12,795 | 11.13M |
| 102 | STOK | Stoke Therapeutics, Inc. | 2.11B | 0.22% | 3,237 | 184.42M |
| 103 | ZYME | Zymeworks Inc. | 2.08B | 0.39% | 465 | 105.97M |
| 104 | TRVI | Trevi Therapeutics, Inc. | 2.08B | 1.50% | 13,851 | - |
| 105 | SNDX | Syndax Pharmaceuticals, Inc. | 2.06B | 1.56% | 238 | 172.35M |
| 106 | OCUL | Ocular Therapeutix, Inc. | 2.06B | 1.29% | 6,030 | 51.95M |
| 107 | MESO | Mesoblast Limited | 2.05B | -0.78% | 9,605 | 65.38M |
| 108 | TYRA | Tyra Biosciences, Inc. | 1.99B | 0.57% | 518 | - |
| 109 | RXRX | Recursion Pharmaceuticals, Inc. | 1.91B | 1.69% | 397,117 | 74.68M |
| 110 | GLPG | Galapagos NV | 1.91B | 0.67% | 577 | 1.31B |
| 111 | PHVS | Pharvaris N.V. | 1.91B | 0.05% | - | - |
| 112 | SION | Sionna Therapeutics, Inc. | 1.88B | - | 1,852 | - |
| 113 | PVLA | Palvella Therapeutics, Inc. | 1.87B | 0.54% | 1,311 | - |
| 114 | NTLA | Intellia Therapeutics, Inc. | 1.86B | 2.87% | 66,719 | 67.67M |
| 115 | HRMY | Harmony Biosciences Holdings, Inc. | 1.86B | 0.03% | 18,563 | 868.45M |
| 116 | NUVB | Nuvation Bio Inc. | 1.83B | 2.94% | 23,561 | 62.90M |
| 117 | TSHA | Taysha Gene Therapies, Inc. | 1.81B | 1.37% | 32,778 | 9.77M |
| 118 | ATAI | AtaiBeckley Inc. | 1.81B | 1.62% | 128,238 | 4.09M |
| 119 | RAPP | Rapport Therapeutics, Inc. | 1.78B | 0.68% | 4,903 | - |
| 120 | INVA | Innoviva, Inc. | 1.76B | 0.80% | 157 | 411.33M |
| 121 | VIR | Vir Biotechnology, Inc. | 1.76B | 0.74% | 20,918 | 68.56M |
| 122 | NRIX | Nurix Therapeutics, Inc. | 1.72B | 0.91% | 2,270 | 71.78M |
| 123 | VCEL | Vericel Corporation | 1.71B | 1.38% | 2 | 276.26M |
| 124 | GLUE | Monte Rosa Therapeutics, Inc. | 1.69B | 1.01% | 2,329 | 123.67M |
| 125 | OCS | Oculis Holding AG | 1.62B | 0.87% | 1,650 | 1.51M |
| 126 | DMRA | Damora Therapeutics, Inc. | 1.62B | 0.82% | 42 | - |
| 127 | GENB | Generate Biomedicines, Inc. | 1.62B | 1.92% | 253 | 31.89M |
| 128 | MBX | MBX Biosciences, Inc. | 1.58B | - | 601 | - |
| 129 | BHVN | Biohaven Ltd. | 1.56B | 1.81% | 1,114 | - |
| 130 | AGIO | Agios Pharmaceuticals, Inc. | 1.55B | 0.61% | 12,057 | 54.03M |
| 131 | IOVA | Iovance Biotherapeutics, Inc. | 1.54B | 1.35% | 110,226 | 263.50M |
| 132 | BCAX | Bicara Therapeutics Inc. | 1.52B | 0.48% | 1,716 | - |
| 133 | CRVS | Corvus Pharmaceuticals, Inc. | 1.51B | 5.19% | 20,365 | - |
| 134 | NBTX | Nanobiotix S.A. | 1.50B | 3.31% | 800 | 38.27M |
| 135 | IMCR | Immunocore Holdings plc | 1.50B | -0.19% | - | 400.02M |
| 136 | IMTX | Immatics N.V. | 1.50B | 0.13% | 1 | 56.67M |
| 137 | ANAB | AnaptysBio, Inc. | 1.50B | 0.39% | 1,761 | 234.60M |
| 138 | ARDX | Ardelyx, Inc. | 1.48B | 1.51% | 4,155 | 407.32M |
| 139 | VRDN | Viridian Therapeutics, Inc. | 1.46B | 0.53% | 15,656 | 70.85M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.45B | 0.24% | 10,047 | - |
| 141 | WVE | Wave Life Sciences Ltd. | 1.43B | 0.95% | 6,277 | 42.73M |
| 142 | PGEN | Precigen, Inc. | 1.40B | -0.66% | 2,109 | 9.68M |
| 143 | NVAX | Novavax, Inc. | 1.39B | 0.71% | 76,411 | 1.12B |
| 144 | AVBP | ArriVent BioPharma, Inc. | 1.37B | 2.31% | 4 | - |
| 145 | MAZE | Maze Therapeutics, Inc. | 1.36B | 6.81% | 51,442 | 2.50M |
| 146 | SVRA | Savara Inc. | 1.34B | 0.19% | 280 | - |
| 147 | GHRS | GH Research PLC | 1.28B | -0.24% | 3,768 | - |
| 148 | MLTX | MoonLake Immunotherapeutics | 1.24B | 0.64% | 2,525 | - |
| 149 | ABCL | AbCellera Biologics Inc. | 1.22B | 1.00% | 262,738 | 75.13M |
| 150 | URGN | UroGen Pharma Ltd. | 1.22B | 0.84% | 8,202 | 109.79M |
| 151 | MPLT | MapLight Therapeutics, Inc. | 1.22B | -0.40% | 47 | - |
| 152 | ZBIO | Zenas BioPharma, Inc. | 1.22B | 2.24% | 551 | 10.00M |
| 153 | PHAR | Pharming Group N.V. | 1.21B | -0.06% | 756 | 376.13M |
| 154 | DBVT | DBV Technologies S.A. | 1.19B | 0.50% | 4,475 | 5.64M |
| 155 | EYPT | EyePoint, Inc. | 1.18B | 0.21% | 20,448 | 31.37M |
| 156 | SEPN | Septerna, Inc. | 1.16B | - | - | 45.95M |
| 157 | JBIO | Jade Biosciences, Inc. | 1.13B | - | 214 | - |
| 158 | AKTS | Aktis Oncology, Inc. | 1.13B | - | 196 | 6.50M |
| 159 | IVA | Inventiva S.A. | 1.12B | -1.11% | 123 | 7.94M |
| 160 | QURE | uniQure N.V. | 1.12B | 1.38% | 22,349 | 16.10M |
| 161 | ORIC | ORIC Pharmaceuticals, Inc. | 1.08B | 1.13% | 8,545 | - |
| 162 | CTMX | CytomX Therapeutics, Inc. | 1.04B | 1.05% | 3,826 | 76.20M |
| 163 | XERS | Xeris Biopharma Holdings, Inc. | 1.04B | 2.04% | 20,061 | 291.85M |
| 164 | PHAT | Phathom Pharmaceuticals, Inc. | 1.03B | 0.93% | 460 | 175.11M |
| 165 | ANNX | Annexon, Inc. | 1.02B | 1.61% | 20,351 | - |
| 166 | SANA | Sana Biotechnology, Inc. | 1.02B | 0.81% | 143,800 | - |
| 167 | EVMN | Evommune, Inc. | 1.01B | 0.50% | 862 | 13.00M |
| 168 | KALV | KalVista Pharmaceuticals, Inc. | 1.00B | 0.98% | 4,910 | 73.62M |
| 169 | FTRE | Fortrea Holdings Inc. | 970.53M | 0.58% | 6,478 | 2.72B |
| 170 | GERN | Geron Corporation | 967.76M | 0.67% | 63,493 | 183.88M |
| 171 | CMPX | Compass Therapeutics, Inc. | 967.07M | 2.48% | 26,024 | 850.00K |
| 172 | OMER | Omeros Corporation | 966.91M | 1.28% | 22,863 | - |
| 173 | MGTX | MeiraGTx Holdings plc | 963.52M | 2.36% | 14,896 | 81.39M |
| 174 | MRVI | Maravai LifeSciences Holdings, Inc. | 940.87M | -0.54% | 7,605 | 185.74M |
| 175 | XNCR | Xencor, Inc. | 935.80M | 1.19% | 51,676 | 125.58M |
| 176 | JANX | Janux Therapeutics, Inc. | 925.86M | -1.55% | 7,809 | 10.00M |
| 177 | ANRO | Alto Neuroscience, Inc. | 916.63M | 2.19% | 280 | - |
| 178 | LBRX | LB Pharmaceuticals Inc | 911.29M | -2.14% | 12 | - |
| 179 | SLS | SELLAS Life Sciences Group, Inc. | 897.91M | -0.60% | 179,946 | - |
| 180 | ABUS | Arbutus Biopharma Corporation | 888.20M | 1.81% | 8,036 | 14.08M |
| 181 | CGEM | Cullinan Therapeutics, Inc. | 875.21M | 1.69% | 780 | - |
| 182 | TBPH | Theravance Biopharma, Inc. | 855.81M | 1.48% | 5,255 | 107.46M |
| 183 | MNKD | MannKind Corporation | 849.19M | 1.85% | 43,463 | 348.97M |
| 184 | DRUG | Bright Minds Biosciences Inc. | 844.51M | -0.48% | 105 | - |
| 185 | KURA | Kura Oncology, Inc. | 839.25M | -0.16% | 4,099 | 67.48M |
| 186 | CBIO | Crescent Biopharma, Inc. | 830.02M | 1.71% | 949 | 10.84M |
| 187 | DSGN | Design Therapeutics, Inc. | 819.62M | 1.13% | 170 | - |
| 188 | VOR | Vor Biopharma Inc. | 817.66M | -0.53% | 4,932 | - |
| 189 | SGP | SpyGlass Pharma, Inc. | 817.28M | -0.08% | - | - |
| 190 | ALLO | Allogene Therapeutics, Inc. | 804.94M | 0.87% | 41,409 | 22.00K |
| 191 | FBRX | Forte Biosciences, Inc. | 803.86M | 0.47% | 30 | - |
| 192 | SPRY | ARS Pharmaceuticals, Inc. | 792.22M | 1.76% | 2,236 | 84.28M |
| 193 | SLDB | Solid Biosciences Inc. | 786.17M | -2.08% | 2,110 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 783.81M | 1.09% | 379 | 49.80M |
| 195 | RLMD | Relmada Therapeutics, Inc. | 755.20M | 0.84% | 2,634 | - |
| 196 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 731.64M | -3.36% | 6,546 | - |
| 197 | GYRE | Gyre Therapeutics, Inc. | 718.64M | 1.14% | 59 | 116.59M |
| 198 | DRTS | Alpha Tau Medical Ltd. | 712.88M | 2.53% | 16,205 | - |
| 199 | TENX | Tenax Therapeutics, Inc. | 688.11M | 1.61% | 5 | - |
| 200 | ARVN | Arvinas, Inc. | 685.66M | 0.94% | 20,875 | 262.60M |
| 201 | PRME | Prime Medicine, Inc. | 678.21M | 0.52% | 1,602 | 4.63M |
| 202 | KYTX | Kyverna Therapeutics, Inc. | 677.64M | 15.29% | 1,048,489 | - |
| 203 | ANL | Adlai Nortye Ltd. | 648.80M | 1.63% | 6,191 | 5.00M |
| 204 | EIKN | Eikon Therapeutics, Inc. | 635.59M | -0.01% | - | - |
| 205 | PROK | ProKidney Corp. | 634.02M | 0.48% | 7,505 | 893.00K |
| 206 | TRAX | First Tracks Biotherapeutics, Inc. | 625.83M | 5.94% | 1,432 | - |
| 207 | ZVRA | Zevra Therapeutics, Inc. | 614.12M | 0.67% | 7,066 | 106.47M |
| 208 | ABSI | Absci Corporation | 612.09M | 2.56% | 64,919 | 2.80M |
| 209 | OCGN | Ocugen, Inc. | 608.22M | 1.69% | 161,553 | 4.41M |
| 210 | RIGL | Rigel Pharmaceuticals, Inc. | 596.50M | - | 464 | 294.28M |
| 211 | STTK | Shattuck Labs, Inc. | 595.58M | 1.55% | 396 | 1.00M |
| 212 | CRMD | CorMedix Inc. | 590.51M | 1.22% | 2,683 | 311.71M |
| 213 | ACRS | Aclaris Therapeutics, Inc. | 579.61M | - | 1,444 | 7.83M |
| 214 | PRTA | Prothena Corporation plc | 574.40M | 2.60% | 2,016 | 9.68M |
| 215 | ENGN | enGene Therapeutics Inc. | 570.08M | 2.77% | 65 | - |
| 216 | STRO | Sutro Biopharma, Inc. | 569.08M | 0.61% | 894 | 102.48M |
| 217 | ARMP | Armata Pharmaceuticals, Inc. | 564.14M | 4.05% | 9,211 | 4.90M |
| 218 | LYEL | Lyell Immunopharma, Inc. | 557.67M | 0.31% | 255 | 36.00K |
| 219 | VSTM | Verastem, Inc. | 536.72M | 0.99% | 19,233 | 30.91M |
| 220 | AGMB | AgomAb Therapeutics NV | 533.67M | 0.41% | 57 | - |
| 221 | VALN | Valneva SE | 529.55M | -4.72% | 5,505 | 205.07M |
| 222 | TECX | Tectonic Therapeutic, Inc. | 529.50M | 2.03% | 968 | - |
| 223 | ADCT | ADC Therapeutics SA | 522.75M | 0.24% | 97 | 81.36M |
| 224 | IMMX | Immix Biopharma, Inc. | 522.17M | 1.76% | 7,444 | - |
| 225 | CADL | Candel Therapeutics, Inc. | 517.12M | 0.86% | 6,475 | - |
| 226 | UPB | Upstream Bio, Inc. | 512.09M | 1.62% | 811 | 2.85M |
| 227 | FULC | Fulcrum Therapeutics, Inc. | 509.49M | 1.59% | 8,691 | 80.00M |
| 228 | ZURA | Zura Bio Limited | 501.92M | 1.49% | 56 | - |
| 229 | FDMT | 4D Molecular Therapeutics, Inc. | 498.26M | 1.24% | 569 | 85.21M |
| 230 | CTNM | Contineum Therapeutics, Inc. | 490.97M | - | - | - |
| 231 | DNA | Ginkgo Bioworks Holdings, Inc. | 486.04M | 1.71% | 11,733 | 170.16M |
| 232 | LXEO | Lexeo Therapeutics, Inc. | 483.79M | 3.82% | 1,490 | - |
| 233 | MDXG | MiMedx Group, Inc. | 479.87M | 0.94% | 33,808 | 418.63M |
| 234 | VTVT | vTv Therapeutics Inc. | 477.77M | - | 876 | 17.00K |
| 235 | CLYM | Climb Bio, Inc. | 477.69M | 6.72% | 16,984 | - |
| 236 | AURA | Aura Biosciences, Inc. | 477.28M | 0.94% | 3,698 | - |
| 237 | RGNX | REGENXBIO Inc. | 474.88M | 0.99% | 5,129 | 170.44M |
| 238 | LRMR | Larimar Therapeutics, Inc. | 472.67M | -0.44% | 16,222 | - |
| 239 | XOMA | XOMA Royalty Corporation | 471.62M | 0.19% | 2 | 52.15M |
| 240 | TRDA | Entrada Therapeutics, Inc. | 470.52M | 0.08% | - | 25.42M |
| 241 | PALI | Palisade Bio, Inc. | 465.43M | -0.71% | 104,894 | - |
| 242 | IVVD | Invivyd, Inc. | 455.31M | 1.26% | 18,029 | 53.43M |
| 243 | ALT | Altimmune, Inc. | 452.77M | 2.05% | 15,300 | 41.00K |
| 244 | BNTC | Benitec Biopharma Inc. | 451.48M | 0.19% | - | - |
| 245 | NMRA | Neumora Therapeutics, Inc. | 442.36M | 4.74% | 42,200 | - |
| 246 | AVIR | Atea Pharmaceuticals, Inc. | 439.79M | -0.29% | 1 | - |
| 247 | ASMB | Assembly Biosciences, Inc. | 436.22M | 2.04% | 1,214 | 72.30M |
| 248 | EPRX | Eupraxia Pharmaceuticals Inc. | 433.91M | -0.28% | 763 | - |
| 249 | PRTC | PureTech Health plc | 430.07M | 5.54% | 1,318 | 6.39M |
| 250 | LCTX | Lineage Cell Therapeutics, Inc. | 425.94M | 4.27% | 3,679 | 14.56M |
| 251 | NGNE | Neurogene Inc. | 413.82M | -0.09% | 39 | 925.00K |
| 252 | AUTL | Autolus Therapeutics plc | 409.86M | -0.65% | 5,437 | 75.39M |
| 253 | VNDA | Vanda Pharmaceuticals Inc. | 409.26M | 2.12% | 22,038 | 216.11M |
| 254 | IPSC | Century Therapeutics, Inc. | 406.93M | -1.74% | 3,717 | 109.16M |
| 255 | RCKT | Rocket Pharmaceuticals, Inc. | 404.85M | 1.37% | 15,508 | - |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 391.76M | 1.96% | 715 | 66.98M |
| 257 | IRD | Opus Genetics, Inc. | 390.61M | 2.81% | 17,443 | 14.20M |
| 258 | AVTX | Avalo Therapeutics, Inc. | 389.23M | 1.96% | 280 | 59.00K |
| 259 | OVID | Ovid Therapeutics Inc. | 381.12M | 1.40% | 9,394 | 7.25M |
| 260 | NAGE | Niagen Bioscience, Inc. | 380.37M | 1.90% | 146 | 129.42M |
| 261 | XFOR | X4 Pharmaceuticals, Inc. | 379.14M | 1.10% | 10 | 35.11M |
| 262 | PRLD | Prelude Therapeutics Incorporated | 376.36M | -1.30% | 1,617 | 12.14M |
| 263 | SLN | Silence Therapeutics plc | 375.51M | 2.85% | 298 | 559.00K |
| 264 | PBYI | Puma Biotechnology, Inc. | 369.36M | 0.55% | 101 | 228.37M |
| 265 | YDES | YD Bio Limited | 362.85M | - | - | 510.36K |
| 266 | MNPR | Monopar Therapeutics Inc. | 362.45M | 2.75% | 100 | - |
| 267 | IMRX | Immuneering Corporation | 360.12M | 0.36% | 1,241 | - |
| 268 | SRZN | Surrozen, Inc. | 357.24M | 0.84% | 3 | 3.48M |
| 269 | NAUT | Nautilus Biotechnology, Inc. | 351.85M | - | 515 | - |
| 270 | CABA | Cabaletta Bio, Inc. | 348.44M | - | 6,534 | - |
| 271 | DMAC | DiaMedica Therapeutics Inc. | 345.93M | 0.08% | - | - |
| 272 | BCYC | Bicycle Therapeutics plc | 343.66M | 4.18% | 155 | 72.59M |
| 273 | RZLT | Rezolute, Inc. | 341.74M | 0.30% | 11,143 | - |
| 274 | EDIT | Editas Medicine, Inc. | 330.81M | 2.42% | 1,710 | 40.52M |
| 275 | GLSI | Greenwich LifeSciences, Inc. | 327.52M | 3.19% | 17,647 | - |
| 276 | AVXL | Anavex Life Sciences Corp. | 326.20M | 0.57% | 986 | - |
| 277 | NGEN | NervGen Pharma Corp. | 314.01M | -1.16% | 1,207 | - |
| 278 | LENZ | LENZ Therapeutics, Inc. | 311.35M | 0.61% | 1,016 | 19.09M |
| 279 | FHTX | Foghorn Therapeutics Inc. | 309.94M | 0.19% | 513 | 30.91M |
| 280 | ABEO | Abeona Therapeutics Inc. | 308.13M | 0.39% | 4,091 | 5.82M |
| 281 | ELDN | Eledon Pharmaceuticals, Inc. | 307.66M | 2.27% | 9,648 | - |
| 282 | NERV | Minerva Neurosciences, Inc. | 305.58M | 2.78% | 133 | - |
| 283 | CCCC | C4 Therapeutics, Inc. | 302.49M | -0.64% | 20,602 | 35.95M |
| 284 | ARTV | Artiva Biotherapeutics, Inc. | 299.07M | -3.51% | 8,206 | 251.00K |
| 285 | NBP | NovaBridge Biosciences | 297.22M | -0.12% | 695 | - |
| 286 | ZNTL | Zentalis Pharmaceuticals, Inc. | 293.65M | 3.76% | 9,332 | 26.87M |
| 287 | CLLS | Cellectis S.A. | 292.82M | -1.75% | 4,699 | 79.59M |
| 288 | IKT | Inhibikase Therapeutics, Inc. | 289.72M | 1.80% | 649 | 1.00 |
| 289 | TARA | Protara Therapeutics, Inc. | 287.73M | -0.94% | 3,210 | - |
| 290 | CHRS | Coherus Oncology, Inc. | 286.84M | 2.20% | 6,150 | 42.17M |
| 291 | ACIU | AC Immune SA | 284.71M | 0.87% | 200 | 4.51M |
| 292 | CGEN | Compugen Ltd. | 277.99M | 3.52% | 5,921 | 72.76M |
| 293 | SABS | SAB Biotherapeutics, Inc. | 260.02M | -2.89% | 4,696 | 114.70K |
| 294 | ARCT | Arcturus Therapeutics Holdings Inc. | 255.24M | 1.81% | 1,205 | 82.03M |
| 295 | PLYX | Polaryx Therapeutics, Inc. | 253.29M | 1.52% | 11,725 | - |
| 296 | HELP | Cybin Inc. | 252.68M | 2.43% | 34,065 | - |
| 297 | NKTX | Nkarta, Inc. | 251.66M | 6.33% | 3,874 | - |
| 298 | ADAG | Adagene Inc. | 251.08M | - | 106 | 7.67M |
| 299 | SLGL | Sol-Gel Technologies Ltd. | 248.08M | -1.55% | - | 19.39M |
| 300 | OBIO | Orchestra BioMed Holdings, Inc. | 247.54M | 3.43% | 1,090 | 33.48M |
| 301 | ALEC | Alector, Inc. | 247.21M | -8.94% | 538 | 21.05M |
| 302 | MIST | Milestone Pharmaceuticals Inc. | 242.85M | 3.13% | 21,085 | 1.55M |
| 303 | VYGR | Voyager Therapeutics, Inc. | 240.19M | -2.18% | 21,099 | 40.37M |
| 304 | CAMP | Camp4 Therapeutics Corporation | 239.87M | 0.54% | - | 3.50M |
| 305 | FENC | Fennec Pharmaceuticals Inc. | 230.64M | 2.29% | 6,308 | 44.64M |
| 306 | ACHV | Achieve Life Sciences, Inc. | 227.92M | 1.68% | 4,749 | - |
| 307 | NVCT | Nuvectis Pharma, Inc. | 227.30M | - | 1 | - |
| 308 | KROS | Keros Therapeutics, Inc. | 224.78M | 1.64% | 15 | 244.06M |
| 309 | ELTX | Elicio Therapeutics, Inc. | 224.06M | -0.16% | - | - |
| 310 | ALXO | ALX Oncology Holdings Inc. | 223.73M | 2.65% | 32 | - |
| 311 | MGNX | MacroGenics, Inc. | 220.55M | 4.47% | 43 | 149.50M |
| 312 | CRBU | Caribou Biosciences, Inc. | 220.33M | 1.33% | 11,430 | 11.16M |
| 313 | CDXS | Codexis, Inc. | 219.00M | - | 3,945 | 70.39M |
| 314 | CNTX | Context Therapeutics Inc. | 217.75M | -1.27% | 462 | - |
| 315 | OABI | OmniAb, Inc. | 215.73M | 0.68% | 1,149 | 18.67M |
| 316 | MDWD | MediWound Ltd. | 213.35M | - | 593 | 16.96M |
| 317 | KPTI | Karyopharm Therapeutics Inc. | 206.72M | 2.18% | 309 | 146.07M |
| 318 | ENLV | Enlivex Ltd. | 201.77M | -3.24% | 1,726 | - |
| 319 | ABOS | Acumen Pharmaceuticals, Inc. | 197.14M | 1.68% | 324 | - |
| 320 | SGMT | Sagimet Biosciences Inc. | 197.14M | 2.37% | 4,058 | - |
| 321 | HRTX | Heron Therapeutics, Inc. | 196.08M | 1.96% | 2,497 | 154.90M |
| 322 | KRRO | Korro Bio, Inc. | 194.56M | 1.33% | 70 | 6.39M |
| 323 | TNXP | Tonix Pharmaceuticals Holding Corp. | 194.47M | 1.33% | 3,933 | 13.11M |
| 324 | DTIL | Precision BioSciences, Inc. | 193.52M | 0.81% | 651 | 34.26M |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 190.67M | -3.81% | 1,492 | 7.15M |
| 326 | CNTN | Canton Strategic Holdings, Inc. | 189.80M | 0.90% | 12,916 | - |
| 327 | RNAC | Cartesian Therapeutics, Inc. | 189.54M | 3.47% | 1,845 | 2.80M |
| 328 | PRQR | ProQR Therapeutics N.V. | 189.02M | 3.40% | 18,911 | 19.19M |
| 329 | UNCY | Unicycive Therapeutics, Inc. | 184.21M | 1.23% | 6,645 | - |
| 330 | BDTX | Black Diamond Therapeutics, Inc. | 183.32M | 1.59% | 6,007 | 70.00M |
| 331 | KALA | KALA BIO, Inc. | 181.62M | 5.56% | 73,437 | - |
| 332 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 180.91M | -0.92% | 11,191 | - |
| 333 | PLX | Protalix BioTherapeutics, Inc. | 178.87M | 0.90% | 1,681 | 52.74M |
| 334 | HURA | TuHURA Biosciences, Inc. | 173.57M | -1.80% | 10,970 | - |
| 335 | MOLN | Molecular Partners AG | 165.88M | 2.28% | - | 856.30K |
| 336 | FATE | Fate Therapeutics, Inc. | 163.93M | 4.44% | 9,600 | 6.65M |
| 337 | MENS | Jyong Biotech Ltd. | 163.80M | 0.70% | 13 | - |
| 338 | SPRO | Spero Therapeutics, Inc. | 162.68M | 0.36% | 2,743 | 66.80M |
| 339 | REPL | Replimune Group, Inc. | 160.19M | 4.30% | 253,021 | - |
| 340 | TLSA | Tiziana Life Sciences Ltd | 158.25M | 0.81% | 570 | - |
| 341 | ORMP | Oramed Pharmaceuticals Inc. | 155.72M | - | 644 | 2.00M |
| 342 | GALT | Galectin Therapeutics Inc. | 153.99M | 2.60% | 370 | - |
| 343 | AGEN | Agenus Inc. | 153.30M | 2.11% | 4,561 | 114.20M |
| 344 | TNYA | Tenaya Therapeutics, Inc. | 152.98M | 1.73% | 75,905 | - |
| 345 | CNTB | Connect Biopharma Holdings Limited | 152.04M | 4.26% | 2,426 | 64.00K |
| 346 | HUMA | Humacyte, Inc. | 150.97M | 3.19% | 94,740 | 2.04M |
| 347 | ACOG | Alpha Cognition Inc. | 149.81M | -1.05% | - | 10.22M |
| 348 | KLRS | Kalaris Therapeutics, Inc. | 143.99M | -0.24% | - | - |
| 349 | BMEA | Biomea Fusion, Inc. | 140.26M | 1.57% | 5,421 | - |
| 350 | EQ | Equillium, Inc. | 139.10M | 2.33% | 654 | 4.39M |
| 351 | IPHA | Innate Pharma S.A. | 138.74M | -1.99% | 1,245 | 10.57M |
| 352 | ANTX | AN2 Therapeutics, Inc. | 136.75M | - | 5,476 | - |
| 353 | ONCY | Oncolytics Biotech Inc. | 130.06M | - | 1,076 | - |
| 354 | NTHI | NeOnc Technologies Holdings, Inc. | 127.80M | 0.29% | - | 39.99K |
| 355 | CBUS | Cibus, Inc. | 119.59M | 5.37% | 475 | 3.64M |
| 356 | IFRX | InflaRx N.V. | 118.56M | -5.20% | 30,110 | 34.44K |
| 357 | GNLX | Genelux Corporation | 118.03M | 3.91% | 398 | 8.00K |
| 358 | IMUX | Immunic, Inc. | 117.55M | 0.01% | 51,082 | - |
| 359 | AARD | Aardvark Therapeutics, Inc. | 117.15M | - | 3,335 | - |
| 360 | KZIA | Kazia Therapeutics Limited | 117.01M | 4.52% | 500,293 | 1.27M |
| 361 | CRDF | Cardiff Oncology, Inc. | 116.90M | 3.64% | 12,730 | 593.00K |
| 362 | VANI | Vivani Medical, Inc. | 116.81M | - | 3,941 | - |
| 363 | PEPG | PepGen Inc. | 114.72M | 3.09% | 4,787 | - |
| 364 | SEER | Seer, Inc. | 112.84M | 0.25% | 1 | 16.58M |
| 365 | CGTX | Cognition Therapeutics, Inc. | 109.01M | 4.27% | 62,375 | - |
| 366 | PYXS | Pyxis Oncology, Inc. | 108.70M | 1.17% | 254 | 13.86M |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 108.57M | 1.74% | 214 | 35.58M |
| 368 | SGMO | Sangamo Therapeutics, Inc. | 107.79M | 1.05% | 103,746 | 39.55M |
| 369 | COYA | Coya Therapeutics, Inc. | 107.43M | 1.10% | 2,671 | 7.95M |
| 370 | ALDX | Aldeyra Therapeutics, Inc. | 102.31M | 1.19% | 13,236 | - |
| 371 | NRXP | NRx Pharmaceuticals, Inc. | 100.43M | 3.05% | 166,572 | 1.23M |
| 372 | TTRX | Turn Therapeutics Inc. | 99.79M | -0.24% | 127 | - |
| 373 | ANIX | Anixa Biosciences, Inc. | 99.24M | 2.78% | 2,819 | - |
| 374 | RANI | Rani Therapeutics Holdings, Inc. | 97.62M | 3.19% | 29,937 | 1.63M |
| 375 | PMN | ProMIS Neurosciences, Inc. | 96.22M | 2.01% | 90 | - |
| 376 | QTTB | Q32 Bio Inc. | 93.92M | - | 183,415 | 53.74M |
| 377 | GUTS | Fractyl Health, Inc. | 93.60M | 2.61% | 66,663 | 3.00K |
| 378 | COEP | Coeptis Therapeutics Holdings, Inc. | 93.35M | 0.47% | 349 | 1.36M |
| 379 | INO | Inovio Pharmaceuticals, Inc. | 92.59M | - | 1,224 | 65.34K |
| 380 | EXOZ | eXoZymes, Inc. | 88.86M | 1.24% | - | -700.00 |
| 381 | GANX | Gain Therapeutics, Inc. | 88.29M | - | 173 | - |
| 382 | ACET | Adicet Bio, Inc. | 88.14M | 1.74% | 890 | - |
| 383 | GOSS | Gossamer Bio, Inc. | 86.84M | -1.96% | 81,545 | 48.47M |
| 384 | PYPD | PolyPid Ltd. | 86.64M | 1.32% | 25 | - |
| 385 | LONA | LeonaBio, Inc. | 86.61M | 0.98% | 279 | - |
| 386 | ATHE | Alterity Therapeutics Limited | 85.74M | -5.25% | 1,953 | 4.43M |
| 387 | ATYR | aTyr Pharma, Inc. | 83.53M | 3.45% | 10,422 | 190.00K |
| 388 | NRXS | NeurAxis, Inc. | 82.23M | 0.96% | 11,671 | 3.57M |
| 389 | CSBR | Champions Oncology, Inc. | 81.93M | 1.72% | 1,381 | 57.95M |
| 390 | MCRB | Seres Therapeutics, Inc. | 81.48M | 0.82% | 50 | 789.00K |
| 391 | FLNA | Filana Therapeutics, Inc. | 81.16M | -1.18% | 14,512 | - |
| 392 | OKYO | OKYO Pharma Limited | 80.82M | -0.65% | 1,086 | - |
| 393 | MAIA | MAIA Biotechnology, Inc. | 80.69M | 0.76% | 6,922 | - |
| 394 | PLRX | Pliant Therapeutics, Inc. | 78.63M | -1.55% | 1,116 | - |
| 395 | IMMP | Immutep Limited | 78.16M | 0.27% | 191,688 | 5.28M |
| 396 | SPRB | Spruce Biosciences, Inc. | 77.53M | 9.31% | 16,076 | 697.00K |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 77.39M | -0.60% | 1,476 | - |
| 398 | ESLA | Estrella Immunopharma, Inc. | 77.22M | 0.83% | 36 | - |
| 399 | PTHS | Pelthos Therapeutics Inc. | 77.18M | -0.12% | 35 | 16.80M |
| 400 | XBIT | XBiotech Inc. | 76.83M | -0.60% | - | - |
| 401 | TCRX | TScan Therapeutics, Inc. | 75.73M | -0.79% | 11,132 | 10.33M |
| 402 | PDSB | PDS Biotechnology Corporation | 73.68M | -1.49% | 26,210 | - |
| 403 | GRCE | Grace Therapeutics, Inc. | 73.47M | 1.88% | 50,144 | - |
| 404 | IBO | Impact BioMedical Inc. | 73.24M | -2.62% | 5,154 | 32.00K |
| 405 | FBIO | Fortress Biotech, Inc. | 72.46M | 0.90% | 4,045 | 63.26M |
| 406 | BYSI | BeyondSpring Inc. | 71.59M | 0.05% | 3,535 | 1.88M |
| 407 | MNOV | MediciNova, Inc. | 70.85M | 1.37% | 139 | 409.66K |
| 408 | ICCC | ImmuCell Corporation | 70.75M | 1.30% | 100 | 27.64M |
| 409 | CING | Cingulate Inc. | 68.96M | 1.19% | 4,964 | - |
| 410 | ACRV | Acrivon Therapeutics, Inc. | 68.67M | 0.70% | 5,636 | - |
| 411 | IBIO | iBio, Inc. | 67.71M | 2.08% | 34,439 | 300.00K |
| 412 | OKUR | OnKure Therapeutics, Inc. | 66.73M | 1.43% | 182 | - |
| 413 | ANVS | Annovis Bio, Inc. | 66.53M | 3.59% | 1,195 | - |
| 414 | IMA | ImageneBio, Inc. | 65.77M | 1.20% | 2,942 | 800.00K |
| 415 | EDSA | Edesa Biotech, Inc. | 64.60M | -4.97% | 21,822 | - |
| 416 | HYFT | MindWalk Holdings Corp. | 61.59M | 2.42% | 612 | 20.70M |
| 417 | INKT | MiNK Therapeutics, Inc. | 59.44M | 1.96% | 463 | - |
| 418 | OSTX | OS Therapies Incorporated | 58.01M | - | 28,156 | - |
| 419 | ACTU | Actuate Therapeutics, Inc. | 56.91M | 5.96% | 8,602 | - |
| 420 | ENTX | Entera Bio Ltd. | 56.88M | 2.52% | 15,043 | 42.00K |
| 421 | TIL | Instil Bio, Inc. | 56.43M | -0.25% | - | - |
| 422 | MGX | Metagenomi Therapeutics, Inc. | 56.05M | -0.67% | 1,693 | 25.21M |
| 423 | KZR | Kezar Life Sciences, Inc. | 53.78M | -0.47% | - | - |
| 424 | RADX | Radiopharm Theranostics Limited | 53.34M | -1.20% | 338 | 10.86M |
| 425 | RNTX | Rein Therapeutics Inc. | 52.99M | 1.07% | 2,516 | - |
| 426 | DWTX | Dogwood Therapeutics, Inc. | 52.11M | 2.30% | 3,217 | - |
| 427 | MREO | Mereo BioPharma Group plc | 52.08M | 0.71% | 33,595 | 500.00K |
| 428 | NTRB | Nutriband Inc. | 50.81M | 1.32% | 131 | 2.28M |
| 429 | ATOS | Atossa Therapeutics, Inc. | 50.63M | 1.91% | 565 | - |
| 430 | PSTV | Plus Therapeutics, Inc. | 49.41M | 0.84% | 11,063 | 5.21M |
| 431 | XLO | Xilio Therapeutics, Inc. | 49.27M | -0.29% | 20 | 43.77M |
| 432 | CUE | Cue Biopharma, Inc. | 49.06M | -25.03% | 2,857,756 | 27.47M |
| 433 | HYPD | Hyperion DeFi, Inc. | 47.73M | 7.16% | 11,279 | 813.46K |
| 434 | TELO | Telomir Pharmaceuticals, Inc. | 47.45M | -0.72% | 2,339 | - |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 46.79M | -1.26% | 473,300 | 90.00K |
| 436 | RNXT | RenovoRx, Inc. | 44.15M | 3.23% | 1,805 | 1.12M |
| 437 | HOWL | Werewolf Therapeutics, Inc. | 43.86M | -0.24% | 2,515 | 1.14M |
| 438 | RLYB | Rallybio Corporation | 43.85M | 1.09% | 980 | 858.00K |
| 439 | LITS | Lite Strategy, Inc. | 41.09M | 1.77% | 14 | - |
| 440 | LIXT | Lixte Biotechnology Holdings, Inc. | 41.01M | 1.44% | 382 | - |
| 441 | ATRA | Atara Biotherapeutics, Inc. | 40.89M | 0.20% | 2,404 | 120.77M |
| 442 | SNSE | Sensei Biotherapeutics, Inc. | 40.69M | 2.28% | 171 | - |
| 443 | ALGS | Aligos Therapeutics, Inc. | 40.53M | -0.15% | 10,153 | 2.19M |
| 444 | NXTC | NextCure, Inc. | 39.06M | -0.27% | - | - |
| 445 | CRVO | CervoMed Inc. | 38.89M | 7.97% | 11,805 | 4.01M |
| 446 | VERU | Veru Inc. | 38.04M | 1.69% | 468 | 16.89M |
| 447 | INMB | INmune Bio Inc. | 37.75M | 3.65% | 2,211 | 50.00K |
| 448 | EVAX | Evaxion A/S | 37.53M | - | 279 | 7.53M |
| 449 | PTN | Palatin Technologies, Inc. | 37.07M | 3.19% | 28 | 8.96M |
| 450 | CELU | Celularity Inc. | 36.91M | 4.92% | 331 | 40.58M |
| 451 | SNTI | Senti Biosciences, Inc. | 36.13M | 5.45% | 21,006 | 22.00K |
| 452 | DARE | Daré Bioscience, Inc. | 35.09M | 2.12% | 34,798 | 1.03M |
| 453 | BOLD | Boundless Bio, Inc. | 34.79M | -1.75% | 2,775 | - |
| 454 | TVGN | Tevogen Bio Holdings Inc. | 34.56M | -4.05% | 1,754 | - |
| 455 | PLUR | Pluri Inc. | 33.63M | -0.77% | 210 | 1.34M |
| 456 | ABVC | ABVC BioPharma, Inc. | 31.38M | 4.80% | 329 | 797.92K |
| 457 | CVM | CEL-SCI Corporation | 30.83M | 1.31% | 805 | - |
| 458 | LTRN | Lantern Pharma Inc. | 30.82M | 2.61% | 5,291 | - |
| 459 | LGVN | Longeveron Inc. | 30.75M | 2.94% | 2,761 | 1.20M |
| 460 | OTLK | Outlook Therapeutics, Inc. | 30.60M | -8.42% | 2,565,799 | 205.70K |
| 461 | DYAI | Dyadic International, Inc. | 30.48M | -1.97% | - | 3.09M |
| 462 | IGC | IGC Pharma, Inc. | 29.82M | -2.32% | 179,900 | 1.11M |
| 463 | TVRD | Tvardi Therapeutics, Inc. | 29.65M | - | - | - |
| 464 | LSTA | Lisata Therapeutics, Inc. | 29.45M | 2.52% | 261 | 170.00K |
| 465 | SKYE | Skye Bioscience, Inc. | 28.98M | -0.02% | 5,675 | - |
| 466 | BCTX | BriaCell Therapeutics Corp. | 28.79M | -0.50% | 3,530 | - |
| 467 | KYNB | Kyntra Bio, Inc. | 28.58M | 0.25% | 75 | 6.44M |
| 468 | JSPR | Jasper Therapeutics, Inc. | 28.56M | 6.25% | 1,614 | - |
| 469 | APLM | Apollomics, Inc. | 28.17M | -2.17% | 3 | 6.93M |
| 470 | NNVC | NanoViricides, Inc. | 27.64M | 1.59% | 14,302 | - |
| 471 | TPST | Tempest Therapeutics, Inc. | 27.25M | 7.33% | 24,191 | - |
| 472 | AEON | AEON Biopharma, Inc. | 26.57M | -2.78% | 826 | - |
| 473 | NEUP | Neuphoria Therapeutics Inc. | 26.25M | -0.02% | - | 14.99M |
| 474 | MRKR | Marker Therapeutics, Inc. | 26.01M | 0.32% | 411 | 3.55M |
| 475 | SER | Serina Therapeutics, Inc. | 24.51M | -2.45% | 4,271 | 130.00K |
| 476 | NRSN | NeuroSense Therapeutics Ltd. | 24.39M | 2.17% | 666 | - |
| 477 | VTGN | Vistagen Therapeutics, Inc. | 24.37M | 1.60% | 5,317,628 | 789.00K |
| 478 | BRNS | Barinthus Biotherapeutics plc | 24.10M | 1.02% | 462 | 14.97M |
| 479 | XCUR | Exicure, Inc. | 23.90M | -0.27% | 579 | 500.00K |
| 480 | LEXX | Lexaria Bioscience Corp. | 23.55M | 0.08% | 7,673 | 368.00K |
| 481 | CRIS | Curis, Inc. | 23.03M | -3.87% | 73,437 | 9.44M |
| 482 | ALLR | Allarity Therapeutics, Inc. | 22.46M | 2.90% | 12,339 | 320.00K |
| 483 | PLRZ | Polyrizon Ltd. | 22.11M | -0.56% | 566 | - |
| 484 | QNCX | Quince Therapeutics, Inc. | 21.84M | - | 110,622 | - |
| 485 | VYNE | VYNE Therapeutics Inc. | 21.32M | -0.45% | - | 570.00K |
| 486 | QNTM | Quantum BioPharma Ltd. | 20.07M | 3.49% | 25,583 | - |
| 487 | OSRH | OSR Holdings, Inc. | 19.91M | 1.88% | 29,065 | 2.91M |
| 488 | PASG | Passage Bio, Inc. | 19.89M | 0.32% | 4,486 | - |
| 489 | COCP | Cocrystal Pharma, Inc. | 19.16M | -2.80% | 1,506 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 18.80M | -0.58% | 892 | 3.94M |
| 491 | ICU | SeaStar Medical Holding Corporation | 18.53M | 8.16% | 989 | 1.23M |
| 492 | PBM | Psyence Biomedical Ltd. | 18.46M | -15.17% | 444,746 | - |
| 493 | KTTA | Pasithea Therapeutics Corp. | 17.56M | 2.03% | 1,646 | - |
| 494 | LPCN | Lipocine Inc. | 16.98M | -1.02% | 6,917 | 1.98M |
| 495 | GNTA | Genenta Science S.p.A. | 16.28M | -1.01% | 102 | - |
| 496 | NCEL | NewcelX Ltd. | 16.05M | 4.14% | 2,366 | - |
| 497 | CDT | CDT Equity Inc. | 16.03M | -0.30% | 4,723 | - |
| 498 | JUNS | Jupiter Neurosciences, Inc. | 15.96M | -5.44% | 233 | 21.80K |
| 499 | HIND | Vyome Holdings, Inc. | 15.79M | -0.44% | 10,842 | 319.71K |
| 500 | CVKD | Cadrenal Therapeutics, Inc. | 14.79M | 9.67% | 1,331 | - |